Kiora Pharmaceuticals Inc SEC filings KPHMW

Kiora Pharmaceuticals Inc has 926 filings in SEC EDGAR's recent list, going back to Aug 9, 2006. Its latest annual report, Form ARS, was filed on May 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.

Kiora Pharmaceuticals Inc SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Regulation FD disclosure
Oct 29, 2026 Oct 23, 2026
4 Insider transaction Sep 17, 2026 Sep 17, 2026
3 Initial insider ownership Sep 17, 2026 Sep 8, 2026
SCHEDULE 13G Ownership over 5% (passive) Sep 17, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 8, 2026 Sep 8, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Aug 19, 2026 Aug 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 10, 2026 —
8-K Current report
Results of operations
Aug 7, 2026 Aug 7, 2026
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
8-K Current report
Regulation FD disclosure
Jun 18, 2026 Jun 18, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2026 Jun 10, 2026
424B3 Prospectus May 28, 2026 —
EFFECT Filing May 22, 2026 —
CORRESP Letter to the SEC May 20, 2026 —
UPLOAD Letter from the SEC May 20, 2026 —
S-3 Shelf registration May 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
8-K Current report
Results of operations
May 8, 2026 May 8, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
ARS Annual report to shareholders May 1, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2026 Apr 16, 2026
D Filing Apr 21, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 7, 2026 Apr 3, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 2, 2026 Apr 1, 2026
S-8 Employee stock plan registration Mar 25, 2026 —
8-K Current report
Results of operations
Mar 25, 2026 Mar 25, 2026
10-K Annual report Mar 25, 2026 Dec 31, 2025
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 6, 2026 Mar 3, 2026
4 Insider transaction Mar 6, 2026 Mar 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 29, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
8-K Current report
Results of operations
Nov 7, 2025 Nov 7, 2025
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
EFFECT Filing Sep 19, 2025 —
CORRESP Letter to the SEC Sep 17, 2025 —
UPLOAD Letter from the SEC Sep 16, 2025 —
S-3 Shelf registration Sep 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
8-K Current report
Regulation FD disclosure
Aug 13, 2025 Aug 13, 2025
8-K Current report
Results of operations
Aug 8, 2025 Aug 8, 2025
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
UPLOAD Letter from the SEC Jul 1, 2025 —
CORRESP Letter to the SEC Jun 20, 2025 —
UPLOAD Letter from the SEC Jun 10, 2025 —
8-K Current report
Shareholder vote results
Jun 4, 2025 Jun 4, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Jun 3, 2025 May 30, 2025
8-K Current report
Results of operations
May 9, 2025 May 9, 2025
10-Q Quarterly report May 9, 2025 Mar 31, 2025
DEF 14A Proxy statement Apr 30, 2025 Apr 16, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
8-K Current report
Results of operations
Mar 25, 2025 Mar 25, 2025
S-8 Employee stock plan registration Mar 25, 2025 —
10-K Annual report Mar 25, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2025 —
8-K Current report
Officer or director change
Jan 15, 2025 Jan 10, 2025
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
SC 13G Ownership over 5% (passive) Nov 12, 2024 —
8-K Current report
Results of operations
Nov 8, 2024 Nov 8, 2024
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Regulation FD disclosure
Oct 29, 2024 Oct 29, 2024
4 Insider transaction Sep 12, 2024 Sep 11, 2024
4 Insider transaction Sep 11, 2024 Sep 10, 2024
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Aug 19, 2024 Aug 19, 2024
4 Insider transaction Aug 15, 2024 Aug 14, 2024
8-K Current report
Results of operations
Aug 9, 2024 Aug 9, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Other events
Jul 30, 2024 Jul 30, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
3 Initial insider ownership Jul 3, 2024 Jul 1, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Jul 1, 2024 Jun 28, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 13, 2024 Jun 13, 2024
4 Insider transaction Jun 13, 2024 Jun 13, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jun 7, 2024 Jun 6, 2024
SC 13G Ownership over 5% (passive) May 29, 2024 —
SC 13G Ownership over 5% (passive) May 29, 2024 —
8-K Current report
Results of operations
May 10, 2024 May 10, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
S-8 Employee stock plan registration May 10, 2024 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 3, 2024 May 1, 2024
EFFECT Filing Mar 28, 2024 —
424B3 Prospectus Mar 28, 2024 —
CORRESP Letter to the SEC Mar 26, 2024 —
DEF 14A Proxy statement Mar 25, 2024 May 1, 2024
8-K Current report
Results of operations
Mar 25, 2024 Mar 25, 2024
10-K Annual report Mar 25, 2024 Dec 31, 2023
PRE 14A Preliminary proxy statement Mar 15, 2024 May 1, 2024
UPLOAD Letter from the SEC Mar 4, 2024 —
S-3 Shelf registration Feb 28, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
D Filing Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
8-K Current report
Regulation FD disclosure
Feb 12, 2024 Feb 12, 2024
SC 13G Ownership over 5% (passive) Feb 9, 2024 —
SC 13G Ownership over 5% (passive) Feb 7, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Feb 1, 2024 Jan 31, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Jan 31, 2024 Jan 25, 2024
8-K Current report
Listing notice
Jan 16, 2024 Jan 16, 2024
8-K Current report
Regulation FD disclosure
Nov 9, 2023 Nov 9, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report Nov 6, 2023 Nov 4, 2023
S-8 Employee stock plan registration Oct 13, 2023 —
4 Insider transaction Oct 3, 2023 Sep 29, 2023
4 Insider transaction Oct 3, 2023 Sep 29, 2023
4 Insider transaction Oct 3, 2023 Sep 29, 2023
4 Insider transaction Oct 3, 2023 Sep 29, 2023
4 Insider transaction Oct 3, 2023 Sep 29, 2023
4 Insider transaction Oct 3, 2023 Sep 29, 2023
4 Insider transaction Oct 3, 2023 Sep 29, 2023
4 Insider transaction Oct 3, 2023 Sep 29, 2023
4 Insider transaction Oct 3, 2023 Sep 29, 2023
8-K Current report
Shareholder vote results
Sep 28, 2023 Sep 27, 2023
8-K Current report
Officer or director change, Other events
Sep 21, 2023 Sep 20, 2023
DEFA14A Additional proxy material Sep 1, 2023 —
8-K Current report
Other events
Sep 1, 2023 Aug 31, 2023
3 Initial insider ownership Aug 10, 2023 Aug 1, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 1, 2023 Aug 1, 2023
DEF 14A Proxy statement Jul 21, 2023 Aug 31, 2023
8-K Current report
Listing notice
Jul 20, 2023 Jul 18, 2023
PRE 14A Preliminary proxy statement Jul 11, 2023 Aug 31, 2023
8-K Current report
Shareholder vote results
Jun 21, 2023 Jun 21, 2023
8-K Current report
Material agreement, Other events
Jun 15, 2023 Jun 12, 2023
SC 13G Ownership over 5% (passive) Jun 13, 2023 —
8-K Current report
Material agreement, Bylaw or fiscal year change, Other events
Jun 6, 2023 Jun 2, 2023
424B1 Filing Jun 2, 2023 —
EFFECT Filing Jun 1, 2023 —
S-1/A Amended registration statement Jun 1, 2023 —
CORRESP Letter to the SEC May 31, 2023 —
CORRESP Letter to the SEC May 31, 2023 —
CORRESP Letter to the SEC May 24, 2023 —
CORRESP Letter to the SEC May 24, 2023 —
CORRESP Letter to the SEC May 23, 2023 —
FWP Free writing prospectus May 15, 2023 —
S-1/A Amended registration statement May 12, 2023 —
UPLOAD Letter from the SEC May 9, 2023 —
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
S-1 Registration statement May 5, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 21, 2023
8-K Current report
Other events
Apr 27, 2023 Apr 27, 2023
8-K Current report
Auditor change
Mar 30, 2023 Mar 24, 2023
8-K Current report
Results of operations
Mar 23, 2023 Mar 23, 2023
10-K Annual report Mar 23, 2023 Dec 31, 2022
4 Insider transaction Mar 7, 2023 Mar 3, 2023
4 Insider transaction Mar 7, 2023 Mar 3, 2023
4 Insider transaction Mar 7, 2023 Mar 3, 2023
4 Insider transaction Mar 7, 2023 Mar 3, 2023
4 Insider transaction Mar 7, 2023 Mar 3, 2023
4 Insider transaction Mar 7, 2023 Mar 3, 2023
4 Insider transaction Mar 7, 2023 Mar 3, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KPRX (Nasdaq), KPHMW (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Encinitas, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1372514
Former names
EYEGATE PHARMACEUTICALS INC (until Nov 4, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.